Ypsomed Holding AGXSWX:YPSN +1.91%91 Net Margin % is 22.49% as of Mar. 2026, which is 97% above its 10-year median of 11.43. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF397.52 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 95.72% on this metric.
The historical rank and industry rank for Ypsomed Holding AG's Net Margin % or its related term are showing as below:
XSWX:YPSN'
s Net Margin % Range Over the Past 10 Years
Min: 1.44 Med: 11.43 Max: 30.36
Current: 30.36
XSWX:YPSN's Net Margin % is ranked better than 95.72% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs XSWX:YPSN: 30.36
Ypsomed Holding AG (XSWX:YPSN) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Ypsomed Holding AG Net Margin % Related Terms
Ypsomed Holding AG Net Margin % Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:YPSN vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (XSWX:YPSN) has a Net Margin % of 22.49% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Ypsomed Holding AG and its competitors. This is 97% above median its historical median of 11.43. Over the past decade, Ypsomed Holding AG's Net Margin % has ranged from 1.44 to 30.36. According to the industry distribution chart, Ypsomed Holding AG ranks #35 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Ypsomed Holding AG's Net Margin % too high?
Ypsomed Holding AG's current Net Margin % of 22.49% is 97% above median its 10-year median of 11.43. Over the past 10 years, this metric has ranged from a low of 1.44 to a high of 30.36. The Medical Devices & Instruments industry median Net Margin % is 2.07. Ypsomed Holding AG's value of 22.49% is 986.5% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #35 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #35 out of 817 companies for Net Margin %. This places Ypsomed Holding AG in the top 4% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Ypsomed Holding AG's value of 22.49% is 986.5% above this benchmark. Historically, Ypsomed Holding AG's own Net Margin % has ranged from 1.44 to 30.36 over the past decade. While the company's 10-year median is 11.43 vs. the industry median of 2.07, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Net Margin % of 22.49% is 986.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Net Margin % is 22.49%, which is 97% above median its own 10-year median of 11.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF397.52, compared to a current price of CHF353.00 — trading 11.2% below its estimated fair value. The current Net Margin % is 22.49%, which is 97% above median its 10-year median of 11.43 and 986.5% above the Medical Devices & Instruments industry median of 2.07. Ypsomed Holding AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Net Margin % is 22.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF353.00 is trading 11.2% below its estimated GF Value™ of CHF397.52.
GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:YPSN:
Net Margin %: 22.49% (97% above median its 10-year median of 11.43)
GF Value™: CHF397.52 vs. price of CHF353.00 (11.2% below fair value)
Industry Position: 986.5% above the Medical Devices & Instruments median (#35 of 817)
No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score
Get the complete analysis for XSWX:YPSN
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:YPSN has been successfully added to your 
